TSXV:MBI.H - Post by User
Comment by
dusty6on Jan 08, 2016 3:25pm
![](https://assets.stockhouse.com/kentico-cms/0340-00/images/Sprite.svg#id_Post_Views_Icon)
90 Views
Post# 24441415
RE:RE:RE:RE:RE:0.065.....????
RE:RE:RE:RE:RE:0.065.....????
What news would there be other than what was put out in the last release? We know we have one payee on board and another to be announced. That being said we know we are heading in the right direction. When will Helomics receive any monies for the first tests and when will they receive monies from the second payee? Will we get news of that only when Helomics releases their financials? If that is the case, we might not get the news we all would like to hear until late in the fall. For reasons of commercial confidentiality the specific details of the Helomics(TM) agreements relating to the adoption of the GeneFX Lung trade mark test will not be released until the pre-launch period via press release by Helomics. Given the success of Helomics(TM) diligent marketing activities of the GeneFX Lung trade mark test in a difficult regulatory climate, we hope that the milestones announced previously will be reached before the end of 2016. If they are taking on test from one payee and know that there is another coming on board, what is it they mean by pre launch? If the pre launch is only after they get all the payees { how many are they anticipating?} on board and a thumbs up on the tests. As it says, Mr. jones is hoping for milestones that could possibly come in 2017.